13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001993440
Total reported value
$934.7M
$934.7M
35 檔
15.2%
In Q2 2025, First Turn Management, LLC's U.S. equity holdings reached a combined market value of $934.7M, distributed across 35 disclosed stock positions.
During Q2 2025, First Turn Management, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | INSM | Insmed Inc | Stock-Healthcare | 7.00% | -1.53% | -7.21% | |
| 2 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 5.47% | — | -28.80% | |
| 3 | MIRM | Mirum Pharmaceuticals Inc | Stock-Other | 5.01% | -1.40% | +4.88% | |
| 4 | NUVL | Nuvalent Inc-a | Stock-Other | 4.57% | -3.89% | -3.35% | |
| 5 | ARGX | Argenx Se - Adr | Stock-Healthcare | 4.52% | — | +4.87% | |
| 6 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 4.44% | -0.72% | -15.99% | |
| 7 | ASND | Ascendis Pharma A/S | Stock-Other | 4.34% | -1.95% | EXIT | |
| 8 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 3.86% | -1.23% | -3.34% | |
| 9 | ORIC | Oric Pharmaceuticals Inc | Stock-Other | 3.81% | -0.52% | -0.86% | |
| 10 | NTRA | Natera Inc | Stock-Healthcare | 3.72% | -1.81% | EXIT | |
| 11 | ADMA | Adma Biologics Inc | Stock-Healthcare | 3.71% | — | +92.67% | |
| 12 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 3.27% | — | +46.12% | |
| 13 | PODD | Insulet CORP | Stock-Healthcare | 3.01% | — | +4.17% | |
| 14 | TGTX | Tg Therapeutics Inc | Stock-Healthcare | 3.01% | — | +11.79% | |
| 15 | IRON | Disc Medicine Inc | Stock-Other | 2.96% | — | — | |
| 16 | GH | Guardant Health Inc | Stock-Healthcare | 2.93% | — | -4.25% | |
| 17 | ✓ | Merus N V | Stock-Other | 2.87% | — | -36.86% | |
| 18 | RVMD | Revolution Medicines Inc | Stock-Healthcare | 2.85% | +3.23% | +22.19% | |
| 19 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 2.81% | +2.16% | +22.19% | |
| 20 | BSX | Boston Scientific CORP | Stock-Healthcare | 2.78% | — | -22.07% | |
| 21 | ACLXGBX | Arcellx Inc | Stock-Other | 2.64% | — | — | |
| 22 | APGE | Apogee Therapeutics Inc | Stock-Other | 2.52% | -2.86% | +35.62% | |
| 23 | RDNT | Radnet Inc | Stock-Healthcare | 2.10% | — | +25.47% | |
| 24 | JANX | Janux Therapeutics Inc | Stock-Other | 1.93% | — | +4.01% | |
| 25 | ELVN | Enliven Therapeutics Inc | Stock-Other | 1.91% | +2.45% | -4.69% | |
| 26 | NAMS | NewAmsterdam Pharma Company N.V. | Stock-Other | 1.76% | +0.11% | — | |
| 27 | HQY | Healthequity Inc | Stock-Healthcare | 1.58% | — | -3.68% | |
| 28 | SPRY | Ars Pharmaceuticals Inc | Stock-Other | 1.48% | — | -31.85% | |
| 29 | VERA | Vera Therapeutics Inc | Stock-Other | 1.36% | -1.90% | EXIT | |
| 30 | SLNOEUR | Soleno Therapeutics Inc | Stock-Other | 1.35% | — | +196.52% | |
| 31 | HROW | Harrow Inc | Stock-Other | 1.30% | — | +21.15% | |
| 32 | AKRO | Akero Therapeutics Inc | Stock-Other | 1.14% | — | — | |
| 33 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 1.09% | — | — | |
| 34 | 4XC1 | Kalvista Pharmaceuticals Inc | Stock-Other | 0.45% | — | — | |
| 35 | BBNX | Beta Bionics Inc | Stock-Other | 0.43% | — | — |
According to official SEC Form 13F filings, First Turn Management, LLC reported a total U.S. public equity portfolio value of $934.7M across 35 disclosed positions in Q2 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including INSM, VRNA, MIRM) accounted for 15.2% of total reported equity market value during Q2 2025.
During Q2 2025, First Turn Management, LLC's top holdings by market value included INSM (7.0%)、VRNA (5.5%)、MIRM (5.0%). The largest single position, INSM, represented 7.0% of total portfolio value.
In Q2 2025, First Turn Management, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.